Bruker Corporation

Bruker Corporation is an American manufacturer of high-performance scientific instruments and analytical and diagnostic solutions. Headquartered in Billerica, Massachusetts, the company's mission is to enable scientists to make breakthrough discoveries and develop new applications that enhance the quality of human life.

The company designs, manufactures, and distributes a wide array of advanced scientific instruments, including Nuclear Magnetic Resonance (NMR) spectrometers, mass spectrometry systems, X-ray diffraction analyzers, atomic force microscopes, and various microscopy solutions. These products cater to diverse market segments such as life science research, applied and pharmaceutical applications, materials research, cell biology, preclinical imaging, clinical phenomics and proteomics research, and clinical microbiology. Bruker operates through key segments including Bruker Scientific Instruments (BSI), which encompasses BioSpin, CALID, and Nano groups, and Bruker Energy & Supercon Technologies (BEST).

Led by Chairman, President, and CEO Frank Laukien, Bruker maintains a strong market position through continuous investment in research and development and strategic acquisitions. Notable recent acquisitions include PhenomeX in 2023, and NanoString Technologies assets and ELITechGroup in 2024. The company has recently introduced new NMR products and workflow solutions, as well as the MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System in April 2026. Bruker reported full-year 2025 revenues of $3.44 billion.